Twitter Facebook LinkedIn YouTube

Sona Nanotech (CSE:SONA) New Listing

Video Platform Video Management Video Solutions Video Player

Halifax-based Sona is a nano technology life sciences firm that has developed two proprietary methods for the manufacture of rod shaped gold nanoparticles. Its principal business is the research and development of its proprietary technology for use in multiplex diagnostic testing platforms that will improve performance over existing tests in the market.

Tags:

Additional Information:

Company: Sona Nanotech
Website: http://www.sonanano.com
Stock Symbol: CSE: SONA
Date Published: Oct 5, 2018
Transcript: Available

Video Transcript:

I’m Erica James for Investmentpitch Media

Sona Nanotech is one of the latest new listing on the Canadian Securities Exchange, trading under the symbol “SONA”, having previously traded on the TSX Venture Exchange as Stockport Exploration.

Halifax-based Sona is a nano technology life sciences firm that has developed two proprietary methods for the manufacture of rod shaped gold nanoparticles.

Its principal business is the research and development of its proprietary technology for use in multiplex diagnostic testing platforms that will improve performance over existing tests in the market.

SONA™ Gold nanorods are manufactured using patent pending and proprietary methods that result in high-quality nanomaterials with long shelf lives, and some significantly improved surface properties

Sona has two gold nanorod market ready products – Gemini, for diagnostic uses, and Omni, for medical applications – with no major further research and development required.

The company is speaking with researchers in academia and industry across the world about commercializing its breakthrough development and plans to the market through licencing and supply agreements with leading manufacturers and developers.

Dr Shine Xu Zhang, industrial research chair in applied nanotechnology at Cape Breton University, stated: “I am very optimistic about the future of Sona; the gold nanorods they make are very versatile, with huge application potential in various fields.”

One of the exciting applications of gold nanorods that will potentially drive global commercialization of gold nanorod technology will be their use as a carrier device to deliver payloads of drug molecules to cells, tissue, or organs.

An example is intractable pain, such as chronic pain or cancer-related pain, treatment and management where a nano-tool/nano-device for this treatment consists of gold nanorods wrapped in high-density lipoproteins.

Research on this topic has demonstrated the high efficiency of the gold nanorods for delivering the pain relieving agents over other nanoparticles.

It is expected that Sona's gold nano technologies may be adapted for use in applications, as a safe and effective delivery system for multiple medical treatments, pending the approval of various regulatory boards including Health Canada and the FDA.

The company closed a private placement for gross proceeds of $2,000,000 from the issuance of 8 million shares at a price of $0.25 per share.

The proceeds will be used to fund business development and for general working capital.

The shares are currently trading at $0.20.

For more information, please visit the company’s website at www.sonanano.com, contact Darren Rowes, President & CEO, at 902-442-0653 or email darren@sonanano.com.

I’m Erica James for Investmentpitch Media